Cargando…
Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification
SIMPLE SUMMARY: The resistance formation of cancer cells to chemotherapeutic drugs is one of the main reasons for the failure of cancer therapy. In order to combat drug resistance and improve the efficacy of chemotherapeutic drugs, we studied the role of the multifaceted hsa-miR-200c in different tu...
Autores principales: | Köhler, Bianca, Dubovik, Sviatlana, Hörterer, Elisa, Wilk, Ulrich, Stöckl, Jan Bernd, Tekarslan-Sahin, Hande, Ljepoja, Bojan, Paulitschke, Philipp, Fröhlich, Thomas, Wagner, Ernst, Roidl, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688189/ https://www.ncbi.nlm.nih.gov/pubmed/36428646 http://dx.doi.org/10.3390/cancers14225554 |
Ejemplares similares
-
A proteomic analysis of an in vitro knock-out of miR-200c
por: Ljepoja, Bojan, et al.
Publicado: (2018) -
Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A
por: Ljepoja, Bojan, et al.
Publicado: (2019) -
A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF-7 breast cancer cells
por: Sommer, Ann-Katrin, et al.
Publicado: (2018) -
Downregulation of GRK5 hampers the migration of breast cancer cells
por: Sommer, Ann-Katrin, et al.
Publicado: (2019) -
The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)